| Protective roles of autophagy in retinal pigment epithelium under high glucose condition via regulating PINK1/Parkin pathway and BNIP3L C Huang, H Lu, J Xu, H Yu, X Wang, X Zhang Biological Research 51, 1-9, 2018 | 36 | 2018 |
| CircFAT1 regulates retinal pigment epithelial cell pyroptosis and autophagy via mediating m6A reader protein YTHDF2 expression in diabetic retinopathy C Huang, P Qi, H Cui, Q Lu, X Gao Experimental eye research 222, 109152, 2022 | 34 | 2022 |
| Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy C Dai, P Waduge, L Ji, C Huang, Y He, H Tian, E Zuniga-Sanchez, ... Cellular and Molecular Life Sciences 79 (1), 63, 2022 | 12 | 2022 |
| Secretogranin III selectively promotes vascular leakage in the deep vascular plexus of diabetic retinopathy L Ji, P Waduge, Y Wu, C Huang, A Kaur, P Oliveira, H Tian, J Zhang, ... International Journal of Molecular Sciences 24 (13), 10531, 2023 | 4 | 2023 |
| Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice C Huang, L Ji, A Kaur, H Tian, P Waduge, KA Webster, W Li Biomedicines 11 (7), 1910, 2023 | 3 | 2023 |
| Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody C Huang, A Kaur, L Ji, H Tian, KA Webster, W Li Gene Therapy, 1-7, 2024 | | 2024 |
| Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy C Huang, P Waduge, A Kaur, H Tian, CY Weng, JT Stout, IH Pang, ... International Journal of Molecular Sciences 25 (17), 9507, 2024 | | 2024 |
| Ex vivo ligandomics to profile diabetic vs. healthy retinal cells for drug target discovery W Li, P Waduge, C Huang, Y Li, J Li Investigative Ophthalmology & Visual Science 65 (7), 317-317, 2024 | | 2024 |
| Anti-Scg3 therapy of oxygen-induced retinopathy in a canine model B Zhang, C Huang, GJ Louise, D Jackson, P Waduge, RA Veettil, X Lin, ... Investigative Ophthalmology & Visual Science 65 (7), 296-296, 2024 | | 2024 |
| Generation of optimal humanized Scg3-neutralizing antibodies for anti-angiogenic therapy C Huang, A Kaur, P Waduge, CY Weng, H Tian, W Li Investigative Ophthalmology & Visual Science 65 (7), 6115-6115, 2024 | | 2024 |
| Anti-Scg3 gene therapy for choroidal neovascularization C Huang, L Ji, A Kaur, H Tian, KA Webster, W Li Investigative Ophthalmology & Visual Science 64 (8), 793-793, 2023 | | 2023 |
| Exploiting retinal endothelial heterogeneity for disease-targeted therapy of diabetic retinopathy P Waduge, L Ji, Y Wu, C Huang, A Kaur, P Oliveira, H Tian, J Zhang, ... Investigative Ophthalmology & Visual Science 64 (8), 997-997, 2023 | | 2023 |
